A continuous-time hidden Markov model for cancer surveillance using serum biomarkers with application to hepatocellular carcinoma
From MaRDI portal
Publication:2272464
DOI10.1007/S40300-019-00151-8zbMath1427.62126OpenAlexW2945961828WikidataQ64449505 ScholiaQ64449505MaRDI QIDQ2272464
Takashi Kumada, Thomas G. Bird, Philip J. Johnson, Ruben Amoros, Hidenori Toyoda, Ruth King
Publication date: 10 September 2019
Published in: Metron (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s40300-019-00151-8
Applications of statistics to biology and medical sciences; meta analysis (62P10) Markov processes: estimation; hidden Markov models (62M05)
Related Items (4)
Direct statistical inference for finite Markov jump processes via the matrix exponential ⋮ Multistate capture-recapture models for irregularly sampled data ⋮ On the estimation of partially observed continuous-time Markov chains ⋮ Guest editor's introduction to the special issue on ``Hidden Markov models: theory and applications
Uses Software
Cites Work
- Unnamed Item
- Inference from iterative simulation using multiple sequences
- A Bayesian screening approach for hepatocellular carcinoma using multiple longitudinal biomarkers
- Individual Prediction in Prostate Cancer Studies Using a Joint Longitudinal Survival–Cure Model
- Frequentist and Bayesian approaches for a joint model for prostate cancer risk and longitudinal prostate-specific antigen data
- A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker
This page was built for publication: A continuous-time hidden Markov model for cancer surveillance using serum biomarkers with application to hepatocellular carcinoma